Related Experiment Video
Updated: Feb 1, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Activated Rho GTPases in Cancer-The Beginning of a New Paradigm
1Rudbeck Laboratory, Department of Immunology, Genetics and Pathology (IGP), Uppsala University, SE 751 85 Uppsala, Sweden. pontus.aspenstrom@igp.uu.se.
Abstract:
Involvement of Rho GTPases in cancer has been a matter of debate since the identification of the first members of this branch of the Ras superfamily of small GTPases. The Rho GTPases were ascribed important roles in the cell, although these were restricted to regulation of cytoskeletal dynamics, cell morphogenesis, and cell locomotion, with initially no clear indications of direct involvement in cancer progression. This paradigm has been challenged by numerous observations that Rho-regulated pathways are often dysregulated in cancers. More recently, identification of point mutants in the Rho GTPases Rac1, RhoA, and Cdc42 in human tumors has finally given rise to a new paradigm, and we can now state with confidence that Rho GTPases serve as oncogenes in several human cancers. This article provides an exposé of current knowledge of the roles of activated Rho GTPases in cancers.
Insights
Rho GTPases, initially linked to cell structure, are now recognized as oncogenes in human cancers. Their dysregulation and mutations confirm their role in cancer progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Rho GTPases, part of the Ras superfamily, were initially associated with cytoskeletal regulation and cell motility.
- Their direct involvement in cancer progression was debated due to a lack of clear evidence.
- Dysregulation of Rho-GTPase pathways is frequently observed in various cancers.
Purpose of the Study:
- To review the current understanding of Rho GTPases' roles in cancer.
- To highlight the shift in paradigm regarding Rho GTPases from regulators of cell dynamics to oncogenes.
Main Methods:
- Literature review of studies on Rho GTPases and cancer.
- Analysis of findings related to Rho GTPase mutations and pathway dysregulation in tumors.
Main Results:
- Identification of point mutants in Rho GTPases (Rac1, RhoA, Cdc42) in human tumors.
- Confirmation that Rho GTPases can function as oncogenes in several human cancers.
- Evidence supporting the dysregulation of Rho-regulated pathways in cancer progression.
Conclusions:
- Rho GTPases are confirmed oncogenes in human cancers.
- Activated Rho GTPases play significant roles in cancer development and progression.
- Further research into Rho GTPase functions in cancer is warranted.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Cell Polarization by Rho Proteins
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Cancer

